HomeSYNACT • STO
add
SynAct Pharma AB
Previous close
kr 8.63
Day range
kr 8.63 - kr 9.84
Year range
kr 4.97 - kr 17.28
Market cap
366.91M SEK
Avg Volume
89.29K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 19.17M | -55.93% |
Net income | -18.63M | 57.19% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -521.75K | — |
Effective tax rate | 5.78% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 62.80M | 41.37% |
Total assets | 241.05M | -19.24% |
Total liabilities | 54.06M | -5.11% |
Total equity | 186.99M | — |
Shares outstanding | 41.30M | — |
Price to book | 1.90 | — |
Return on assets | -21.09% | — |
Return on capital | -28.09% | — |
Cash Flow
Net change in cash
| (SEK) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -18.63M | 57.19% |
Cash from operations | -36.15M | -4.32% |
Cash from investing | — | — |
Cash from financing | 47.48M | 26,626.82% |
Net change in cash | 11.25M | 133.28% |
Free cash flow | -34.05M | -38.06% |
About
Founded
Mar 14, 2012
Website
Employees
5
